| | | | Index Performance | | Index | Sensex | Nifty | | Open | 8,535.03 | 2,645.90 | | High | 8,535.03 | 2,663.90 | | Low | 8,166.97 | 2,564.10 | | Today's Cls | 8,197.92 | 2,576.70 | | Prev Cls | 8,446.49 | 2,645.20 | | Change | -248.57 | -68.50 | | % Change | -2.94 | -2.59 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Financial Technology | 443.95 | 3.52 | | Akruti City | 914.85 | 3.33 | | CESC | 205.95 | 2.92 | | Hindustan Zinc | 345.50 | 2.64 | | Piramal Healthcare | 202.00 | 2.46 | | Losers | | Glenmark Pharma | 132.15 | -11.13 | | Aban Offshore | 258.15 | -9.85 | | Oracle Finance | 618.00 | -9.82 | | Ranbaxy Lab | 144.40 | -9.27 | | Welspun Gujarat | 50.90 | -8.94 | | | Market Statistics | | - | BSE | NSE | | Advances | 699 | 276 | | Declines | 1,686 | 888 | | Unchanged | 85 | 50 | | Volume(Nos) | 22.76cr | 52.38cr | | | | | | Market Commentary | | | Selling spree continues | | Across-the-board selling leads to an unabated slide in the market to shed 2.94% for the day. | | The market took a sharp dip after an initial surge and continued moving southwards, as shares across sectors came under the grip of relentless selling pressure. | 
| | | The session was marked with extreme volatility. After a firm opening at 8535, around 89 points above its previous close of 8446, the markets failed to capitalise on the gains and drifted into the negative territory in the afternoon. Heavyweights as well as banking, gas & oil, power, FMCG and capital goods stocks contributed to the fall and dragged the index to an intra-day low of 8167. Sensex finally closed ended 2.94% or 249 points lower at 8198, while Nifty pared 69 points to 2577.
Market breadth was extremely negative with losing stocks outnumbering the gainers by a wide margin. Of the 2,468 stocks traded on the BSE, 1,679 stocks declined, whereas 703 stocks advanced. Eighty stocks ended unchanged. Among the sectoral indices, BSE Bankex shed 4.15% followed by BSE Oil & Gas (down 3.71%), BSE Power (down 3.26%) and BSE FMCG (down 3.26%).
Of the 30 stocks trading in Sensex basket, only five stocks managed to close in the positive territory. Among the major losers, Ranbaxy Laboratories tumbled by 9.27% at Rs144.40, ICICI Bank plunged 5.17% at Rs269.60, Tata Power slumped 5.07% at Rs640.10, Reliance Industries dropped 5% at Rs1,149.10, HDFC Bank shed 4.54% at Rs800.70, Hindustan Unilever lost 4.50% at Rs230.05 and Bharat Heavy Electricals declined by 3.84% at Rs1,284.30. Other frontline stocks were down by 1-3% each. Sun Pharmaceutical Industries however bucked the downtrend and rose 2.19% at Rs997.60 while JP Associates at Rs66.70, Tata Consultancy Services gained 0.42% at Rs463, Wipro advanced 0.19% at Rs206.25 and Sterlite Industries at Rs245.50 was up around 0.04% each.
Over 86.85 lakh shares of Satyam Computer Services changed hands on the BSE followed by Punjab National Bank (81 lakh shares), Unitech ( 78 lakh shares), ICICI Bank (77 lakh shares) and JP Associates (68.26 lakh shares). | | | | | | | | European Indices at 16:00 IST on 05-03-2009 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 7433.49 | 142.53 | 1.95 | | Hang Seng Index | 12211.24 | -119.91 | -0.97 | | Kospi Index | 1058.18 | -1.08 | -0.10 | | Straits Times Index | 1518.18 | -1.08 | -0.10 | | Jakarta Composite Index | 1288.07 | -1.30 | -1.30 | | | | | | | | | | | Asian Indices at close on 05-03-2009 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 3593.87 | -52.00 | -1.43 | | CAC 40 Index | 2643.97 | -31.71 | -1.19 | | DAX INDEX | 3823.46 | -67.48 | -1.73 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
